Alere, a provider of diagnostic tools to manage patients own health, has completed the acquisition of Arriva Medical for $65m.

Alere also paid 806,452 restricted shares from its common stock.

Florida-based Arriva Medical provides diabetes testing supplies to individuals in their homes and has revenues of approximately $21.5m for the six months ended 31 October 2011.

Alere’s new product development efforts focus on cardiology, infectious disease, oncology, toxicology and women’s health.